Profil bibliographique

Michael Wichroski

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

46Publications signalées

1869Citations signalées

3Affiliations récentes

Les institutions déclarées

Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Belgium)

Les domaines associés

Cancer Immunotherapy and BiomarkersHepatitis B Virus StudiesNeuroblastoma Research and TreatmentsPhagocytosis and Immune RegulationHepatitis C virus research

Les publications récentes

2025 article OpenAlex

Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408

Denise C. Grünenfelder, Upender Velaparthi, Jayakumar Warrier, Louis Chupak et autres

de, be, se, in, us, ie (code pays fourni par la source)

2 citations Journal of Medicinal Chemistry

Accès ouvert 2025 other OpenAlex

Figure S3 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Table S2 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Figure S6 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Figure S1 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Figure S7 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Table S4 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Table S3 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Figure S2 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Table S5 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Figure S4 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Accès ouvert 2025 other OpenAlex

Table S1 from Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Michael Wichroski, Si-Qi Liu, Lauren M. Zasadil, Joseph L. Benci et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.